Lv31
322 积分 2023-07-07 加入
Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice
3小时前
待确认
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
4小时前
已完结
The role of hydrophilic linkers in next-generation antibody-drug conjugates
3天前
已完结
Understanding the increasing incidence of neuroendocrine tumors
5天前
已完结
Second-line treatment strategies and clinical outcomes after progression on chemoimmunotherapy in extensive-stage small-cell lung cancer
6天前
已完结
Recent advances and future strategies in first-line treatment of ES-SCLC
6天前
已完结
From Molecular Targets and Cancer Therapeutics
7天前
已完结
Identification of an allosteric site on the E3 ligase adapter cereblon
12天前
已完结
Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration
19天前
已关闭
Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
29天前
已完结
皖公网安备34019202002308
